INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09969 INNOCARE

Trading 10-30 15:04:00

11.230

-0.440

-3.77%

High11.720	Low11.160	Vol3.51M
Open11.560	D1 Closing11.670	Amplitude4.80%
Mkt Cap19.84B	Tradable Cap16.78B	Total Shares1.77B
T/O40.04M	T/O Rate0.24%	Tradable Shares1.49B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"INNOCARE","latestPrice":11.23,"timestamp":1793343831122,"preClose":11.67,"halted":0,"volume":3512800,"delay":0,"changeRate":-0.03770351328191941,"floatShares":1494000000,"shares":1767000000,"eps":0.4479764958773644,"marketStatus":"Trading","change":-0.44,"latestTime":"10-30 15:04:00","open":11.56,"high":11.72,"low":11.16,"amount":40041281,"amplitude":0.047986,"askPrice":11.24,"askSize":6000,"bidPrice":11.22,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.9039199000682531,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1793347800000},"marketStatusCode":2,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":11.67,"openAndCloseTimeList":[[1793323800000,1793332800000],[1793336400000,1793347200000]],"volumeRatio":0.58586,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"Innocare Pharma Limited","latestPrice":24.3,"timestamp":1793343600000,"preClose":24.69,"halted":0,"volume":9203600,"delay":0,"premium":"-60.80"}},"requestUrl":"/m/hq/s/09969","defaultTab":"news","newsList":[{"id":"2679942157","title":"InnoCare Pharma (SEHK:9969) Climbed, What Is Driving Attention Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2679942157","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679942157?lang=en_us&edition=fundamental","pubTime":"2026-10-29 11:39","pubTimestamp":1793245196,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (SEHK:9969) drew fresh attention after presenting new orelabrutinib data at the ESMO 2026 Congress, highlighting high response rates, durable outcomes and manageable safety across several lymphoma and leukemia settings.\nFor investors watching the tape, InnoCare Pharma’s 1-day share price return of 2.01% sits alongside a 30-day share price decline of 17.38% and a year-to-date share price fall of 6.80%. The 3-year total shareholder return of 84.92% contrasts with a 1-year total...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-climbed-what-is-driving-attention-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-climbed-what-is-driving-attention-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146297411","title":"Goldman Sachs Raises Innocare Price Target to HK$23.16, Keeps 'Buy' Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1146297411","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146297411?lang=en_us&edition=fundamental","pubTime":"2026-10-28 15:36","pubTimestamp":1793172976,"startTime":"0","endTime":"0","summary":"Goldman Sachs has released a research report stating that Innocare (09969) reported third-quarter total revenue above the bank's expectations. The bank raised its 12-month price target for the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IE0002270589.USD","IE00BFXG1179.USD","LU1868837300.USD","LU2471134796.USD","BK4552","LU2896262040.SGD","IE00B19Z3581.USD","LU0345770308.USD","IE0034235188.USD","LU0096364046.USD","IE00B19Z3B42.SGD","LU0868494617.USD","LU1894683264.USD","LU2237443978.SGD","LU2237438978.USD","LU0210536198.USD","LU2750360997.AUD","EWH","LU1668664300.SGD","LU0742534661.SGD","BK4585","LU2237443622.USD","LU0868494708.USD","BK4550","LU1868836757.USD","LU1868836591.USD","LU2237443465.HKD","LU2471134879.HKD","LU0942090050.USD","LU1868836914.USD","GSX","LU0251131958.USD","BK0239","BK4516","BK1161","LU0048573561.USD","LU0061475181.USD","LU1894683348.USD","LU2471134952.CNY","LU0106831901.USD","LU0345770993.USD","LU1868837136.USD","LU1144417596.USD","BK4504","BK4533","688428","IE0004086264.USD","LU2471134523.USD","LU2750360641.GBP","IE0004091025.USD","LU1804176565.USD","LU1791807156.HKD","LU0251142724.SGD","BK4588","GS","BK4127","IE00BSNM7G36.USD","LU2237443549.SGD","LU2265009873.SGD","LU2237443895.HKD","LU2237443382.USD","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105422281","title":"Hong Kong Stock Movers: InnoCare Pharma (09969) Surges Over 4% as First Three Quarters Turn Profitable, Core Product Orelabrutinib Continues Strong Sales Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1105422281","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105422281?lang=en_us&edition=fundamental","pubTime":"2026-10-28 11:32","pubTimestamp":1793158334,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (09969) climbed more than 4%, rising 5.08% to HK$14.49 as of press time, with a turnover of HK$34.8642 million.On the news front, InnoCare Pharma recently announced its results for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688428","VXUS","BK1574","KCAI","BK1161","09969","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678412328","title":"InnoCare Posts Q3 Attributable Profit; Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2678412328","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678412328?lang=en_us&edition=fundamental","pubTime":"2026-10-27 15:22","pubTimestamp":1793085725,"startTime":"0","endTime":"0","summary":"InnoCare Pharma  posted 409.3 million yuan in net profit attributable to shareholders of the listed company for the third quarter, compared with an attributable net loss a year ago.The pharmaceutical company's Hong Kong and Shanghai shares both fell 2% during Tuesday's afternoon trade.EPS was 0.24 yuan, a Monday filing with the Hong Kong Stock Exchange showed.For the three months ended Sept. 30, operating revenue was 962 million yuan, up 151% from a year ago, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09969","FCA","BK0239","688428","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128034064","title":"PBOC Creates Bond Market Non-Bank Swap Facility, Anthropic Plans IPO Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1128034064","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128034064?lang=en_us&edition=fundamental","pubTime":"2026-10-27 07:28","pubTimestamp":1793057310,"startTime":"0","endTime":"0","summary":"China's central bank announced the establishment of a Bond Market Non-Bank Swap Facility (BNSF).The People's Bank of China said it will support systemically important bank wealth management...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","REDS","IPOS","BK4585","03355","BK4588","09141","BK1161","03141","BK1526","00763","BK1607","BK1574","ANT","KCAI","BK1529","BK4127","BK1506","09969","FRHC","BK1149","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146178710","title":"InnoCare Pharma Posts RMB 656 Million Net Profit Attributable to Shareholders for First Three Quarters, Reversing Year-Earlier Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1146178710","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146178710?lang=en_us&edition=fundamental","pubTime":"2026-10-26 16:58","pubTimestamp":1793005094,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (09969) released its results for the first three quarters of 2026, reporting total operating revenue of RMB 2.099 billion, up 88.21% from the same period a year earlier.Pharmaceutical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688428","BK1161","09969","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178934247","title":"Morgan Stanley: Preview of Q4 Catalysts for Chinese Biotech Stocks, Sector Rated \"Attractive\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1178934247","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178934247?lang=en_us&edition=fundamental","pubTime":"2026-10-23 15:18","pubTimestamp":1792739896,"startTime":"0","endTime":"0","summary":"Morgan Stanley has released a research report identifying and previewing potential catalysts that could affect the stock prices of Chinese biotech companies in the fourth quarter of 2026, assigning...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828714.EUR","BK4504","LU0149534421.HKD","01801","LU2097828557.USD","MS","LU1732799900.SGD","LU1969619763.USD","LU1989772923.USD","LU0314104364.USD","LU2347655156.SGD","LU0210528500.USD","LU2089284900.SGD","LU1989772840.SGD","LU0502904849.HKD","LU2097828631.EUR","LU0463099449.HKD","BK1583","02162","BK4516","LU0882574139.USD","LU2111349929.HKD","LU2357305700.SGD","LU2476274720.SGD","LU0795875169.SGD","IE00B3S45H60.SGD","LU1244550221.USD","LU1668664300.SGD","LU1720051108.HKD","BK4127","IE00BKVL7J92.USD","BK1587","LU2488822045.USD","LU0971096721.USD","LU1791710400.SGD","LU1064131342.USD","LU1720051017.SGD","LU0106261372.USD","BK4534","LU0053666078.USD","LU0455707207.USD","LU1548497426.USD","LU2028103732.USD","IE00B775SV38.USD","LU0234570918.USD","LU0557290698.USD","LU0006306889.USD","LU2023251221.USD","LU2778985437.USD","LU0106831901.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU1988902786.USD","LU2487616109.SGD","HK0000165453.HKD","KURE","LU0225283273.USD","LU2271345857.HKD","BK4585","BK4588","BK1161","LU1791710582.SGD","BK4581","LU0244354667.USD","LU1831875114.USD","KBWB","IE00B5MMRT66.SGD","LU0795875086.SGD","LU1732800096.USD","LU0158827781.USD","LU0158827948.USD","BIOY","LU1074936037.SGD","IAI","09969","LU0320765646.SGD","LU0390134368.USD","LU0912757837.SGD","LU0607220059.USD","IE00B543WZ88.USD","LU2264538146.SGD","LU1162221912.USD","LU1244550494.USD","02256","LU0528227936.USD","LU2097828805.USD","BK1589","IE00BZ1G4Q59.USD","LU1244550577.SGD","LU2133065610.SGD","LU2097828474.EUR","LU1188198961.HKD","LU2328871848.SGD","BK1574","LU1363072403.SGD","LU0098860793.USD","TBXU","LU2089283258.USD","LU0267386448.USD","LU2242644610.SGD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676499527","title":"Why Did InnoCare Pharma (SEHK:9969) Move Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2676499527","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676499527?lang=en_us&edition=fundamental","pubTime":"2026-10-18 19:25","pubTimestamp":1792322754,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (SEHK:9969) is back on investors’ radar after three orelabrutinib studies were picked for oral presentation at JSH 2026, highlighting real-world and Phase II blood cancer data.\nDespite the positive sentiment around orelabrutinib and mesutoclax this week, InnoCare Pharma’s recent trading tells a mixed story. The share price at HK$12.32 comes after a 30 day share price return down 16.25% and a 1 year total shareholder return down 12.5%. However, the 3 year total shareholder...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/why-did-innocare-pharma-sehk9969-move-today","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/why-did-innocare-pharma-sehk9969-move-today","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","09969","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676444405","title":"How Orelabrutinib Data Will Impact InnoCare Pharma Stock Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2676444405","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676444405?lang=en_us&edition=fundamental","pubTime":"2026-10-17 17:35","pubTimestamp":1792229738,"startTime":"0","endTime":"0","summary":"InnoCare Pharma reported a string of pipeline milestones, including new orelabrutinib data in multiple blood cancers, a registrational Phase III launch for mesutoclax in marginal zone lymphoma, and IND clearance for bispecific antibody ICP-B161 in autoimmune disease.\nThe cluster of hematology and immunology updates points to heavier late stage development activity around orelabrutinib and mesutoclax, which could influence how investors think about future product mix and R&D spend.\nThe next...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/how-orelabrutinib-data-will-impact-innocare-pharma-stock-inv","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/how-orelabrutinib-data-will-impact-innocare-pharma-stock-inv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","BK4211","09969","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148490496","title":"HK Movers | Biotech Stocks Fall Broadly; AKESO Down Over 10%, ZAI LAB Down Over 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148490496","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148490496?lang=en_us&edition=fundamental","pubTime":"2026-10-14 09:49","pubTimestamp":1791942575,"startTime":"0","endTime":"0","summary":"On Wednesday, Hong Kong-listed biotech and pharmaceutical stocks fell broadly. $AKESO(09926)$ dropped more than 10%, $ZAI LAB(09688)$ declined over 8%, $BEONE MEDICINES(06160)$, $INNOCARE(09969)$ and $REMEGEN(09995)$ each fell more than 3%, and $SKB BIO(06990)$ slid over 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969","06990","09995","06160","09688","09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103707635","title":"InnoCare Sets 26 October Board Meeting to Review Nine-Month 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1103707635","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103707635?lang=en_us&edition=fundamental","pubTime":"2026-10-12 16:41","pubTimestamp":1791794505,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited will convene its Board of Directors on 26 October 2026 to consider and approve the unaudited third-quarter results covering the nine months ended 30 September 2026. The agenda...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155830129","title":"InnoCare Turns Profitable and Lands Major Partnership, Yet Founding Families Keep Offloading Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1155830129","media":"Deep News","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155830129?lang=en_us&edition=fundamental","pubTime":"2026-10-10 14:40","pubTimestamp":1791614444,"startTime":"0","endTime":"0","summary":"In the first half of 2026, InnoCare Pharma Limited (ASX: 09969) recorded operating revenue of 1.137 billion yuan, up 55.46% year on year, while net profit attributable to shareholders reached 246...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688428","BK1574","BK1161","BK0239","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674862996","title":"Should Eli Lilly Drug Deal Require Action From InnoCare Pharma (SEHK:9969) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2674862996","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674862996?lang=en_us&edition=fundamental","pubTime":"2026-10-10 02:24","pubTimestamp":1791570264,"startTime":"0","endTime":"0","summary":"InnoCare Pharma announced a research collaboration and license agreement with Eli Lilly to pursue up to five drug targets addressing critical unmet medical needs.\nThe Eli Lilly partnership provides external validation for InnoCare Pharma's late stage pipeline, with potential implications for future commercialization and cash flow mix.\nThis article examines how InnoCare Pharma's investment narrative is shaped by the Eli Lilly collaboration around up to five targets.\n\nScan how the Eli Lilly...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/should-eli-lilly-drug-deal-require-action-from-innocare-phar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/should-eli-lilly-drug-deal-require-action-from-innocare-phar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JOYT","RGLO","BK1574","09969","GXDW","ISBC","DECU","BK4211","FEBU","PMDE","VOTE","VGFPF","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674042020","title":"InnoCare Pharma (SEHK:9969) Stock Dropped, So What Is Driving Attention Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2674042020","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674042020?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:35","pubTimestamp":1791473706,"startTime":"0","endTime":"0","summary":"InnoCare Pharma (SEHK:9969) drew fresh attention after announcing a research collaboration and license agreement with Eli Lilly to develop new medicines, including potential eligibility for up to US$3.35b in combined upfront and milestone payments.\nFor investors watching the tape, InnoCare Pharma’s share price has come under pressure, with a 7-day share price return down 15.21% and a 30-day share price return down 15.04%. At the same time, the 3-year total shareholder return remains up...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-stock-dropped-so-what-is-driving-at","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-stock-dropped-so-what-is-driving-at","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165973977","title":"Hong Kong Stock Market Movers: Innovative Drug Stocks Deepen Losses in Afternoon Session, Ascletis Pharma-B (01672) Falls Over 10%, Innovent Bio (01801) Drops Nearly 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165973977","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165973977?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:08","pubTimestamp":1791439696,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, losses among innovative drug concept stocks widened in the afternoon session. As of press time, Ascletis Pharma-B (01672) fell 9.82% to HK$7.62; InnoCare (09969)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","IBBQ","KCAI","01477","LU0455707207.USD","LU0502904849.HKD","LNGR","LU1969619763.USD","LU2488822045.USD","MEDX","VXUS","01530","BK1589","LU0149534421.HKD","06978","BK1583","LU0326950275.SGD","LU2242644610.SGD","159992","HK0000165453.HKD","LU0463099449.HKD","LU2097828557.USD","LU2097828474.EUR","LU2097828631.EUR","BK1574","BK4585","09969","LU1831875114.USD","LU0607220059.USD","LU1188198961.HKD","LU0244354667.USD","BK1191","BK1593","BK1515","01801","LU2097828714.EUR","LU2097828805.USD","LU2328871848.SGD","KURE","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138896611","title":"Movement Alert｜INNOCARE Falls 5.11% in Regular Trading, Shareholder Selling and Biotech Sector Pullback Weigh","url":"https://stock-news.laohu8.com/highlight/detail?id=1138896611","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138896611?lang=en_us&edition=fundamental","pubTime":"2026-10-08 10:38","pubTimestamp":1791427098,"startTime":"0","endTime":"0","summary":"On October 8, INNOCARE fell 5.11% in regular trading, changing hands at 12.83 HKD with turnover of 68.13 million HKD. The decline came as shareholder stake reductions and a broader biotech sector...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139023729","title":"Movement Alert｜INNOCARE Falls 5.01% in Regular Trading, Biotech Sector Pullback Weighs on Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1139023729","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139023729?lang=en_us&edition=fundamental","pubTime":"2026-10-07 09:48","pubTimestamp":1791337682,"startTime":"0","endTime":"0","summary":"On October 7, INNOCARE fell 5.01% in regular trading, trading at 13.27 HKD/share, with turnover of 3.8525 million HKD.On the news front, the broader biotechnology sector suffered a sharp pullback,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"INNOCARE Slumps on Biotech Pullback Amid Eli Lilly Deal","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109821073","title":"InnoCare Pharma Posts Marginal Share Increase in September; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1109821073","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109821073?lang=en_us&edition=fundamental","pubTime":"2026-10-06 16:44","pubTimestamp":1791276271,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited reported minimal equity movement for September 2026, with total issued shares edging up by 0.58 million to 1.77 billion across its dual listings in Hong Kong and on Shanghai’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106900427","title":"Movement Alert｜INNOCARE Rises 5.01% in Regular Trading, Biotechnology Sector Recovery Drives Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1106900427","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106900427?lang=en_us&edition=fundamental","pubTime":"2026-10-06 13:55","pubTimestamp":1791266156,"startTime":"0","endTime":"0","summary":"On October 6, INNOCARE rose 5.01% in regular trading, trading at 14.03 HKD/share, with Turnover of 16.3466 million HKD.The biotechnology sector broadly rebounded, with CANSINOBIO up 12.98%, AKESO up...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"INNOCARE Surges on Eli Lilly Collaboration Boost","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107644890","title":"INNOCARE: Renbin Zhao Disposes of Shares, Long Position Falls to 6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107644890","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107644890?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:52","pubTimestamp":1790934736,"startTime":"0","endTime":"0","summary":"On September 30, 2026, Renbin Zhao sold 5.00 million shares of INNOCARE (09969) on the SEHK open market, an on-exchange active trade.Prior to the disposal, Renbin Zhao's long position in INNOCARE was...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":-0.0068},{"period":"1month","weight":-0.1935},{"period":"3month","weight":-0.1444},{"period":"6month","weight":-0.1562},{"period":"1year","weight":-0.1543},{"period":"ytd","weight":-0.0512}],"compareEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":-0.0638},{"period":"3month","weight":-0.113},{"period":"6month","weight":-0.1093},{"period":"1year","weight":-0.1286},{"period":"ytd","weight":-0.1042}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.103999},{"month":2,"riseRate":0.666667,"avgChangeRate":0.128923},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.010195},{"month":4,"riseRate":0.714286,"avgChangeRate":0.102464},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.059233},{"month":6,"riseRate":0.857143,"avgChangeRate":0.113731},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05509},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.06378},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.016143},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.058678},{"month":11,"riseRate":0.833333,"avgChangeRate":0.100833},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012645}],"exchange":"SEHK","name":"INNOCARE","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INNOCARE,09969,INNOCARE股票,INNOCARE股票老虎,INNOCARE股票老虎国际,INNOCARE行情,INNOCARE股票行情,INNOCARE股价,INNOCARE股市,INNOCARE股票价格,INNOCARE股票交易,INNOCARE股票购买,INNOCARE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}